This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2013 Dec 20;342(6165):1432-3.

doi: 10.1126/science.342.6165.1432.

Breakthrough of the year 2013. Cancer immunotherapy

Jennifer Couzin-Frankel

PMID: 24357284
DOI: 10.1126/science.342.6165.1432

Breakthrough of the year 2013. Cancer immunotherapy

Jennifer Couzin-Frankel. Science. 2013.

. 2013 Dec 20;342(6165):1432-3.

doi: 10.1126/science.342.6165.1432.

Author

Jennifer Couzin-Frankel

PMID: 24357284
DOI: 10.1126/science.342.6165.1432

No abstract available

PubMed Disclaimer

Comment in

Cancer immunotherapy.
McNutt M. McNutt M. Science. 2013 Dec 20;342(6165):1417. doi: 10.1126/science.1249481. Science. 2013. PMID: 24357273 No abstract available.
Immunotherapy: it takes a village.
Pardoll D. Pardoll D. Science. 2014 Apr 11;344(6180):149. doi: 10.1126/science.344.6180.149-a. Science. 2014. PMID: 24723594 Free PMC article.

Similar articles

Cocktails for cancer with a measure of immunotherapy.
Ledford H. Ledford H. Nature. 2016 Apr 14;532(7598):162-4. doi: 10.1038/532162a. Nature. 2016. PMID: 27075078 No abstract available.
Melanoma immunotherapy: historical precedents, recent successes and future prospects.
Raaijmakers MI, Rozati S, Goldinger SM, Widmer DS, Dummer R, Levesque MP. Raaijmakers MI, et al. Immunotherapy. 2013 Feb;5(2):169-82. doi: 10.2217/imt.12.162. Immunotherapy. 2013. PMID: 23413908 Review.
Cancer treatment: The killer within.
Ledford H. Ledford H. Nature. 2014 Apr 3;508(7494):24-6. doi: 10.1038/508024a. Nature. 2014. PMID: 24695297 No abstract available.
Therapeutic use of anti-CTLA-4 antibodies.
Blank CU, Enk A. Blank CU, et al. Int Immunol. 2015 Jan;27(1):3-10. doi: 10.1093/intimm/dxu076. Epub 2014 Jul 18. Int Immunol. 2015. PMID: 25038057 Review.
Role of the crosstalk between CTLA-4 and NKG2D in the development of anti-CTLA-4 treatment strategies.
Demaria S, Dustin ML. Demaria S, et al. Immunotherapy. 2013 Feb;5(2):109-12. doi: 10.2217/imt.12.160. Immunotherapy. 2013. PMID: 23413900 No abstract available.

See all similar articles

Cited by

Expression of SIGLEC15 correlates with tumor immune infiltration, molecular subtypes, and breast cancer progression.
Lai H, Liu Y, Gong Y, Zong C, Zeng W, Chen H. Lai H, et al. PLoS One. 2024 Nov 14;19(11):e0313561. doi: 10.1371/journal.pone.0313561. eCollection 2024. PLoS One. 2024. PMID: 39541298 Free PMC article.
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy.
Gorgulho J, Loosen SH, Masood R, Giehren F, Pagani F, Buescher G, Kocheise L, Joerg V, Schmidt C, Schulze K, Roderburg C, Kinkel E, Fritzsche B, Wehmeyer S, Schmidt B, Kachel P, Rolling C, Götze J, Busch A, Sinn M, Pereira-Veiga T, Wikman H, Geffken M, Peine S, Matschl U, Altfeld M, Huber S, Lohse AW, Beier F, Brümmendorf TH, Bokemeyer C, Luedde T, von Felden J. Gorgulho J, et al. J Exp Clin Cancer Res. 2024 Nov 8;43(1):298. doi: 10.1186/s13046-024-03215-4. J Exp Clin Cancer Res. 2024. PMID: 39511626 Free PMC article.
Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancer.
Ma Y, Zhao X, Feng J, Qiu S, Ji B, Huang L, Hwu P, Logsdon CD, Wang H. Ma Y, et al. iScience. 2024 Sep 30;27(11):111085. doi: 10.1016/j.isci.2024.111085. eCollection 2024 Nov 15. iScience. 2024. PMID: 39473974 Free PMC article.
Comparative Efficacy and Safety of Neoadjuvant Immunotherapy with Nivolumab vs. Pembrolizumab in Resectable Non-Small Cell Lung Cancer: A Systematic Review.
Papaporfyriou A, Bartziokas K, Apessos I, Mueller J, Leivaditis V, Koletsis E, Grapatsas K. Papaporfyriou A, et al. Curr Oncol. 2024 Oct 18;31(10):6289-6299. doi: 10.3390/curroncol31100469. Curr Oncol. 2024. PMID: 39451773 Free PMC article.
Genetically predicted Caspase 8 levels mediates the causal association between CD4+ T cell and breast cancer.
Chen Y, Zheng Z, Wang J, Huang X, Xie L. Chen Y, et al. Front Immunol. 2024 Sep 26;15:1410994. doi: 10.3389/fimmu.2024.1410994. eCollection 2024. Front Immunol. 2024. PMID: 39391306 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations